Publications by authors named "James D Chambers"

47Publications

Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans.

JAMA 2020 05;323(19):1972-1973

Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2020.2229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237961PMC
May 2020

Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs.

J Gen Intern Med 2020 Sep 13;35(9):2629-2636. Epub 2020 Apr 13.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11606-020-05805-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458970PMC
September 2020

What types of real-world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?

Pharmacoepidemiol Drug Saf 2020 Oct 25;29(10):1307-1311. Epub 2020 Mar 25.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.4992DOI Listing
October 2020

Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage.

Health Aff (Millwood) 2019 11;38(11):1882-1886

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2019.00201DOI Listing
November 2019

Variation in US private health plans' coverage of orphan drugs.

Am J Manag Care 2019 10;25(10):508-512

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St #63, Boston, MA 02111. Email:

View Article

Download full-text PDF

Source
October 2019

Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies.

J Manag Care Spec Pharm 2018 Dec;24(12):1240-1246

1 The Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://www.jmcp.org/doi/10.18553/jmcp.2018.24.12.1240
Publisher Site
http://dx.doi.org/10.18553/jmcp.2018.24.12.1240DOI Listing
December 2018

Specialty Drug Coverage Varies Across Commercial Health Plans In The US.

Health Aff (Millwood) 2018 07;37(7):1041-1047

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2017.1553DOI Listing
July 2018

Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia.

J Manag Care Spec Pharm 2018 Jul;24(7):632-642

1 Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2018.24.7.632DOI Listing
July 2018

Insurance coverage for genomic tests.

Science 2018 Apr 19;360(6386):278-279. Epub 2018 Apr 19.

Center for Business Models in Healthcare, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://www.sciencemag.org/lookup/doi/10.1126/science.aas9268
Publisher Site
http://dx.doi.org/10.1126/science.aas9268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991085PMC
April 2018

EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.

Int J Technol Assess Health Care 2017 Jan 25;33(4):534-540. Epub 2017 Oct 25.

University of California at San Francisco,Department of Clinical Pharmacy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462317000903DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732073PMC
January 2017

Drugs Cleared Through The FDA's Expedited Review Offer Greater Gains Than Drugs Approved By Conventional Process.

Health Aff (Millwood) 2017 08;36(8):1408-1415

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2016.1541DOI Listing
August 2017

A Review of Empirical Analyses of Disinvestment Initiatives.

Value Health 2017 Jul - Aug;20(7):909-918. Epub 2017 May 16.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2017.03.015DOI Listing
July 2017

Payer coverage policies for multigene tests.

Nat Biotechnol 2017 07;35(7):614-617

Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt.3912DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553867PMC
July 2017

The influence of time horizon on results of cost-effectiveness analyses.

Expert Rev Pharmacoecon Outcomes Res 2017 Dec 23;17(6):615-623. Epub 2017 May 23.

a Center for the Evaluation of Value and Risk in Health , Institute for Clinical Research and Health Policy Studies, Tufts Medical Center , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2017.1331432DOI Listing
December 2017

The Decline in Vitamin Research Funding: A Missed Opportunity?

Curr Dev Nutr 2017 Aug 5;1(8):e000430. Epub 2017 Apr 5.

Gerald J and Dorothy R Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA.

View Article

Download full-text PDF

Source
https://academic.oup.com/cdn/article/4735232
Publisher Site
http://dx.doi.org/10.3945/cdn.117.000430DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998363PMC
August 2017

Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs.

J Manag Care Spec Pharm 2016 Oct;22(10):1176-81

2 Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2016.22.10.1176DOI Listing
October 2016

Mapping US commercial payers' coverage policies for medical interventions.

Am J Manag Care 2016 Sep 1;22(9):e323-8. Epub 2016 Sep 1.

Tufts University School of Medicine, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, #63, Boston, MA 02111. E-mail:

View Article

Download full-text PDF

Source
September 2016

The impact of formulary drug exclusion policies on patients and healthcare costs.

Am J Manag Care 2016 08;22(8):524-31

Tufts University School of Medicine, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, #63, Boston, MA 02111. E-mail:

View Article

Download full-text PDF

Source
August 2016

The Role of Decision Models in Health Care Policy: A Case Study.

Med Decis Making 2016 07;36(5):666-79

Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Department of Health and Human Services, Rockville, MD, USA (AJ-B, CC, JS, WL)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X16646732DOI Listing
July 2016

Thirty Years of Media Coverage on High Drug Prices in the United States--A Never-Ending Story or a Time for Change?

Value Health 2016 Jan 2;19(1):14-6. Epub 2015 Dec 2.

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2015.10.008DOI Listing
January 2016

CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.

Int J Technol Assess Health Care 2015 Jan 11;31(5):347-54. Epub 2016 Jan 11.

Center for the Evaluation of Value and Risk in Health,Institute for Clinical Research and Health Policy Studies,Tufts Medical Center,Tufts University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462315000525DOI Listing
January 2015

Private payers disagree with Medicare over medical device coverage about half the time.

Health Aff (Millwood) 2015 Aug;34(8):1376-82

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2015.0133DOI Listing
August 2015

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab.

J Oncol Pract 2015 Jul 9;11(4):313-8. Epub 2015 Jun 9.

UNC Eshelman School of Pharmacy; University of North Carolina at Chapel Hill, Gillings School of Global Public Health; UNC Lineberger Comprehensive Cancer Center; Cecil G. Sheps Center for Health Services Research, Chapel Hill, NC; University of Kansas School of Medicine, Kansas City, KS; Dana-Farber Cancer Institute; Tufts Medical Center Institute for Clinical Research and Health Policy Studies; Harvard Medical School; Brigham and Women's Hospital, Boston, MA; University of Chicago, Chicago, IL; Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY; and Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2015.004218
Publisher Site
http://dx.doi.org/10.1200/JOP.2015.004218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507391PMC
July 2015

Medicare's Interventions Coverage: The Authors Reply.

Health Aff (Millwood) 2015 Jun;34(6):1066

Tufts Medical Center Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2015.0446DOI Listing
June 2015

An assessment of the methodological quality of published network meta-analyses: a systematic review.

PLoS One 2015 29;10(4):e0121715. Epub 2015 Apr 29.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, #63, Boston, Massachusetts, 02111, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121715PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414531PMC
February 2016

Medicare is scrutinizing evidence more tightly for national coverage determinations.

Health Aff (Millwood) 2015 Feb;34(2):253-60

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and a professor at the Tufts University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2014.1123DOI Listing
February 2015

The lag from FDA approval to published cost-utility evidence.

Expert Rev Pharmacoecon Outcomes Res 2015 Jun 12;15(3):399-402. Epub 2015 Jan 12.

Tufts Medical Center, Center for the Evaluation of Value and Risk in Health, 800 Washington Street #63, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2015.1001371DOI Listing
June 2015

Medicare's use of cost-effectiveness analysis for prevention (but not for treatment).

Health Policy 2015 Feb 22;119(2):156-63. Epub 2014 Nov 22.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Boston Scientific, Marlborough, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healthpol.2014.11.012DOI Listing
February 2015

Potential role of network meta-analysis in value-based insurance design.

Am J Manag Care 2014 Aug;20(8):641-8

The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Boston, MA 02111. E-mail:

View Article

Download full-text PDF

Source
August 2014

Despite high costs, specialty drugs may offer value for money comparable to that of traditional drugs.

Health Aff (Millwood) 2014 Oct;33(10):1751-60

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine at Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2014.0574DOI Listing
October 2014

Do changes in drug coverage policy point to an increased role for cost-effectiveness analysis in the USA?

Authors:
James D Chambers

Pharmacoeconomics 2014 Aug;32(8):729-33

The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-014-0166-6DOI Listing
August 2014

Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures.

Value Health 2013 Jun 10;16(4):629-38. Epub 2013 May 10.

Health Economics Research Group, Brunel University, Uxbridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2013.02.011DOI Listing
June 2013

Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.

Health Aff (Millwood) 2013 Jun;32(6):1109-15

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, School of Medicine, Tufts University, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2012.1073DOI Listing
June 2013

What can we learn from the U.S. expanded end-stage renal disease bundle?

Health Policy 2013 May 16;110(2-3):164-71. Epub 2013 Feb 16.

The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healthpol.2013.01.011DOI Listing
May 2013

Medicare's enduring struggle to define "reasonable and necessary" care.

N Engl J Med 2012 Nov 31;367(19):1775-7. Epub 2012 Oct 31.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1208386DOI Listing
November 2012

Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss.

J Vasc Surg 2012 Oct 31;56(4):1015-24.e1. Epub 2012 Jul 31.

Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2012.02.069DOI Listing
October 2012

Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits.

Acad Radiol 2012 Sep 29;19(9):1060-5. Epub 2012 Jun 29.

Department of Radiology, Institute for Clinical Research and Health Policy Studies, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2012.05.005DOI Listing
September 2012

A primer on cost-effectiveness analyses for vascular surgeons.

J Vasc Surg 2012 Jun;55(6):1794-800

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2012.02.026DOI Listing
June 2012

Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries.

Health Aff (Millwood) 2012 Apr;31(4):700-8

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2011.1309DOI Listing
April 2012

Factors predicting Medicare national coverage: an empirical analysis.

Med Care 2012 Mar;50(3):249-56

Health Economics Research Group, Brunel University, Uxbridge, UK.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00005650-201203000-000
Publisher Site
http://dx.doi.org/10.1097/MLR.0b013e318241eb40DOI Listing
March 2012

Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement.

Health Aff (Millwood) 2011 Dec;30(12):2329-37

Center for Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2010.1147DOI Listing
December 2011

Listening to Provenge--what a costly cancer treatment says about future Medicare policy.

N Engl J Med 2011 May 6;364(18):1687-9. Epub 2011 Apr 6.

Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1103057DOI Listing
May 2011

Does Medicare have an implicit cost-effectiveness threshold?

Med Decis Making 2010 Jul-Aug;30(4):E14-27. Epub 2010 Jun 15.

Health Economics Research Group, Brunel University, Uxbridge, UK.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0272989X10371134
Publisher Site
http://dx.doi.org/10.1177/0272989X10371134DOI Listing
November 2010